Skip to main content
Yuyu Pharma, Inc. logo

Yuyu Pharma, Inc. — Investor Relations & Filings

Ticker · 000220 ISIN · KR7000220004 KO Manufacturing
Open in API
Filings indexed 304 across all filing types
Latest filing 2020-01-06 Director's Dealing
Country KR South Korea
Listing KO 000220

About Yuyu Pharma, Inc.

https://www.yuyu.co.kr/

Yuyu Pharma, Inc., established in 1941, is a healthcare company focused on the development, manufacturing, and marketing of pharmaceutical products. The company is committed to creating innovative therapeutics to address healthcare challenges and improve quality of life. Its research and development efforts are concentrated on key therapeutic areas, with a notable emphasis on treatments for central nervous system disorders, including Alzheimer's disease. The company operates through several divisions, including Yuyu Healthcare, which provides pharmaceutical-standard Original Design Manufacturer (ODM) and Original Equipment Manufacturer (OEM) services.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an individual (Kim Simon) at Yuyu Pharmaceutical. This type of filing is a standard regulatory requirement for insiders (directors/executives) to disclose their personal shareholdings and changes therein. In the provided classification schema, this corresponds to 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2020-01-06 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Yuyu Pharma regarding the 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정). This filing details the company's plan to sell or transfer its own shares, which falls under the category of share repurchase or disposal activities. According to the provided definitions, 'Transaction in Own Shares' (POS) is the correct classification for reports concerning a company buying back or selling/disposing of its own shares.
2019-12-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is used to disclose changes in share ownership by company insiders (directors/executives). In the provided classification schema, this corresponds to 'Director's Dealing' (DIRS), which covers insider trades and changes in ownership status by company executives.
2019-12-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates, methods (e.g., open market purchases, stock bonuses), and the purpose of holding. This type of document is classified as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2019-11-22 Korean
분기보고서 (2019.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Yuyu Pharma (주식회사 유유제약) covering the period from January 1, 2019, to September 30, 2019. It contains detailed financial information, business descriptions, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-11-14 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Changes in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Yuyu Pharma. It details specific share transactions (purchases) by company executives and major shareholders, including dates, transaction types, and updated ownership percentages. This type of filing is a standard regulatory disclosure for insider/major shareholder activity, which falls under the 'Director's Dealing' (DIRS) category as it reports personal share transactions by company insiders and major shareholders.
2019-08-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.